Collectively, the three bills expand access to the opioid overdose antidote naloxone by exempting it from the dangerous drug list, increase regulations on addiction treatment centers to ensure quality standards are met and require physicians to research a patient’s prescription history more thoroughly.
“The three bills I signed into law today will enable us to more effectively fight the ongoing opioid epidemic that impacts individuals, families and communities across Georgia,” said Mr. Deal. “I am confident that this legislation will help save lives and give hope to the victims ensnared by this epidemic as well as their loved ones.”
More articles on opioids:
Trump administration backpedals on plans to eliminate ‘drug czar’ office: 5 things to know
Independence Blue Cross Foundation launches study to improve ER addiction treatment referrals
More research needed on link between fetal opioid exposure and birth defects, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
